Patent · US Active

Gene therapy for neurodegenerative disorders

US9415119B2 · kind B2 · utility

11Cited by
26References
7Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 6, 2015
Grant dateAug 16, 2016
Priority date
Expiry dateOct 6, 2035

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2750/14171
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compositions and methods for treating disorders affecting motor function, such as motor function affected by disease or injury to the brain and/or spinal cord, are disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.